Lyris to Host Third Quarter Earnings Webcast

Global digital marketing company Lyris, Inc. (OTCBB:LYRI) will report its operating results for the third quarter of fiscal 2012 on Thursday, May 10.

The company will hold a conference call and webcast to discuss its financial results and operating activities open to all interested parties at 8 a.m., Pacific Daylight Time (11 a.m., Eastern Daylight Time), Thursday, May 10, hosted by Wolfgang Maasberg, chief executive officer, Deborah Eudaley, chief financial officer, and Richard McDonald, director of investor relations.

The teleconference can be accessed by calling (719) 325-4797, passcode 9496270. Please dial in 10-15 minutes prior to the beginning of the call. The webcast will be available on the Internet at www.lyris.com with a replay available through Thursday, May 17, at (858) 384-5517, passcode 9496270 on the website.

Lyris (LYRI) Stock Quote and News:

Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/about-2/disclaimer.

0 comments

Add your comment

Commenting is allowed only for registered users.

Other articlesgo to homepage

	Dig-It Underground Stock Chart Analysis Video(0) A spike in volume and rise in share price has Dig-It Underground (Pink Sheets: DIGX) on the radar for more movement in the morning. A thinly-traded stock, volatility has been strong in the chart as the MACD trends upwards towards zero as the chart is making a bounce off the bottom. The Relative Strength Index

	GelTech Receives First Order for FireIce from Turkey(0) GelTech Solutions, Inc. (OTCBB: GLTC) this morning reported receipt of the first order from Turkey through partner Nano Girisim Ltd. Sti. Nano Girism Ltd. Sti., a distributor of industrial products based in Istanbul. Nano Girisim intends to initially promote GelTech’s FireIce, a revolutionary water enhancing fire suppressant for use in fire extinguishers, as Turkish law

	Athersys Meets with FDA to Discuss Suppressing GvHD in Leukemia and other Cancers(0) Graft versus Host Disease (GvHD) is an area of great unmet medical that represents a significant risk to cancer patients throughout the world. The condition occurs when patients receive a bone marrow transplant following radiation and/or chemotherapy, and the transplanted immune cells begin to attack the patient, causing significant pain and disability, or even death.

	Judge Denies Taylor Armstrong’s Request to Dismiss Case with MyMedicalRecords.com, Damages Could Grow in Excess of $3 Million(0) In the latest round of the litigation between MMRGlobal, Inc. (OTCBB: MMRF) company MyMedicalRecords.com (“MMR”) and Beverly Hills Housewife Taylor Armstrong, Los Angeles Superior Court Judge Frederick Shaller dealt a blow to Taylor Armstrong in denying her motion for a summary judgment to have the MyMedicalRecords.com lawsuit against her dismissed. We first broke the story

	Cellceutix CEO Interview on TheStreetBeat Part II(0) Below is Part II of the CEO Interview from TheStreetBeat.com with Cellceutix CEO Leo Ehrlich, including the video and the text script. Question: I’d like to move on with you telling us a bit more about Prurisol. What’s the current status? As we disclosed recently, we have submitted pre-IND documentation to the FDA. We recently

Stay Informed

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.